Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell envelope anionic components are negatively charged molecules on the bacterial surface that maintain structural integrity and regulate ion homeostasis (Nature Reviews Microbiology, 2013). In Gram-negative bacteria, the primary anionic component is the lipid A and core oligosaccharide of lipopolysaccharide (LPS), while Gram-positive bacteria utilize teichoic acids and acidic phospholipids like phosphatidylglycerol (PubMed, PMCID: PMC3163956). These components create a high negative surface charge density that is distinct from the relatively neutral surface of mammalian cells, providing a basis for selective toxicity (StatPearls, 2023). Cationic antimicrobial agents, such as polymyxins and daptomycin, target these polyanions through electrostatic attraction, which leads to the displacement of stabilizing divalent cations and subsequent membrane permeabilization (Journal of Biological Chemistry, 2017). This interaction results in the leakage of essential intracellular components and rapid bacterial cell death, making these components vital targets for treating multi-drug resistant infections (Clinical Microbiology Reviews, 2019). Furthermore, modifications to these anionic components, such as the addition of 4-amino-4-deoxy-L-arabinose to LPS, are a primary mechanism by which bacteria develop resistance to these life-saving drugs (Frontiers in Microbiology, 2020).
Electrostatic binding of cationic drugs to anionic surface components, displacement of divalent cations (Mg2+ and Ca2+), and subsequent membrane disruption or pore formation leading to cell lysis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell envelope anionic components.